Livestock
More than 45 percent of Boehringer Ingelheim Animal Health business’s global revenue comes from our livestock business (poultry, ruminant, swine and Veterinary Public Health), driven by innovative parasiticides, vaccines and therapeutics, as well as our history of partnership with livestock producers, livestock veterinarians, government officials and NGOs.
We bring innovative health solutions to our customers to prevent disease in livestock. In doing so, we help livestock producers produce more high quality food using fewer natural resources.
We also strive to address some of the most pressing challenges facing our livestock customers, such as the need to cost-effectively produce more protein to feed the world's growing population. By 2050, the global population will reach 9.7 billion people, with a significant increase in the middle class, and substantial growth in emerging markets like Africa and Asia. As a result, the demand for animal protein is expected to increase by 70 percent.
In response to a growing public health concern over antibiotic resistance and the need for food safety, we focus on developing solutions that prevent or reduce the need for antibiotics while at the same time improving the quality and safety of our food.
We are here to help our customers tackle these challenges with preventive care solutions. Furthermore, we are increasing our focus on non-traditional animal health offerings, such as point-of-care diagnostic technologies, live biotherapeutics, and digital solutions.
Cattle / Ruminants
In our ruminants strategic business unit we focus on parasiticides, vaccines and therapeutics which are offered to our dairy and beef veterinarians and farmers.
We focus our solutions on innovation and portfolio management that helps prevent disease in ruminants as well as treat them when needed. In turn, our customers are able to produce more high quality food using less natural resources.
We address some of the most pressing challenges of our ruminant customers, such as the need to produce more protein cost effectively to feed the world's growing population.
In response to the public health concern over antibiotic resistance, we aim to develop solutions for the future that prevent or reduce the need for antibiotics while at the same time improving the quality and safety of food.
-
Cattle / Ruminants
Learn how reproductive technologies and animal welfare ensure cows produce more milk, live better and have shorter calving intervals.
-
Cattle / Ruminants
An exclusive drug-based approach to fight worms is dying. Dr. Ray Kaplan, from Georgia University, explains five things you need to know.
-
Cattle / Ruminants
Is it possible to deal with parasites in a sustainable way? A series of free virtual discussions with our experts and academics unveils the latest trends.
-
-
Cattle / Ruminants
From pain management to responsible use of antibiotics, Cattle First introduces a whole cow approach to look after health and productivity.
-
Cattle / Ruminants
Boehringer Ingelheim’s global initiative ‘Cattle First’ fosters health, well-being, innovation and sustainability on cattle farms around the world.
-
Animal Health News
Serkan Erkovan, Senior Global Manager for Ruminant Business, talks about a new scholarship programme to improve awareness of BVD.
-
Animal Health
The award was granted to Bovikalc® Dry at the EuroTier trade fair in Hanover, Germany.
-
Animal Health
The Milk Quality Academy provides a platform for expert discussions around animal well-being and prevention.
-
Animal Health
Helping cattle farmers combat bovine’s farming greatest enemies.
-
Animal Health
The latest BVDV epidemiological data in China published and discussed at the press conference in Shanghai.
-
Animal Health
Boehringer Ingelheim supports and encourages innovation through The Ruminant Well-being Awards.
-
Animal Health
Boehringer Ingelheim brought together a range of experts to discuss the latest insights in the industry.